Summary
Archer-Daniels-Midland Co. (ADM) reported a significant decrease in net earnings for the third quarter of fiscal year 2024 compared to the prior year, primarily driven by a substantial $461 million impairment charge related to its investment in Wilmar. This charge significantly impacted the Ag Services and Oilseeds segment and led to a sharp increase in the effective tax rate. While revenues saw a decline due to lower sales prices across segments, this was partially offset by higher sales volumes. Despite the quarterly earnings pressure, ADM demonstrated resilience in cash flow generation, with operating cash flow increasing year-over-year. The company also continued its strategic acquisitions within the Nutrition segment and repurchased a significant amount of its own stock. However, investors should note the ongoing investigations by the SEC and DOJ concerning intersegment sales, which have led to a material weakness in internal controls over financial reporting. The company is actively implementing remediation measures.
Financial Highlights
48 data points| Revenue | $19.94B |
| Cost of Revenue | $18.57B |
| Gross Profit | $1.36B |
| SG&A Expenses | $905.00M |
| Interest Expense | $174.00M |
| Net Income | $18.00M |
| EPS (Basic) | $0.04 |
| EPS (Diluted) | $0.04 |
| Shares Outstanding (Basic) | 482.00M |
| Shares Outstanding (Diluted) | 483.00M |
Key Highlights
- 1Net earnings attributable to ADM Company decreased significantly to $18 million in Q3 2024 from $821 million in Q3 2023, heavily impacted by a $461 million impairment charge on the Wilmar investment.
- 2Total revenues declined by $1.76 billion to $19.94 billion in Q3 2024 compared to $21.70 billion in Q3 2023, primarily due to lower sales prices across most segments.
- 3Operating cash flow increased to $2.47 billion for the nine months ended September 30, 2024, up from $1.89 billion in the prior year period, indicating strong cash generation.
- 4The company completed several strategic acquisitions in its Nutrition segment during the first nine months of 2024, including Revela Foods, FDL, PT, and TNS, for an aggregate consideration of $948 million.
- 5ADM repurchased $2.33 billion of its common stock during the first nine months of 2024, a substantial increase from $1.12 billion in the same period last year, reflecting a commitment to shareholder returns.
- 6A material weakness in internal control over financial reporting was identified related to intersegment sales disclosures, prompting ongoing remediation efforts and a significant increase in selling, general, and administrative expenses due to higher legal and financing fees.
- 7Dividends paid increased to $0.50 per share in Q3 2024 from $0.45 per share in Q3 2023, showing continued commitment to returning capital to shareholders.